Interfemur Variation of Bone Mineral Density in Patients Receiving High-dose Thyroxin Therapy
暂无分享,去创建一个
[1] A. Kaim,et al. Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma , 1996, European Journal of Nuclear Medicine.
[2] J. Franklyn,et al. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis. , 1995, Thyroid : official journal of the American Thyroid Association.
[3] S. Nagataki,et al. Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women. , 1995, Thyroid : official journal of the American Thyroid Association.
[4] S. Greenspan,et al. Femoral bone loss progresses with age: A longitudinal study in women over age 65 , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] J. Lear,et al. Regional variations in bone mineral density as assessed with dual-energy photon absorptiometry and dual x-ray absorptiometry. , 1993, Radiology.
[6] T. Diamond,et al. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. , 1991, The Journal of clinical endocrinology and metabolism.
[7] W. Hannan,et al. Effect dose equivalent in dual X-ray absorptiometry. , 1990, The British journal of radiology.
[8] F. Fahey,et al. Comparison of bone mineral density in both hips. , 1988, Radiology.
[9] J. Siegel,et al. The Symmetry of Hip Bone Mineral Density: A Dual Photon Absorptiometry Approach , 1987, Clinical nuclear medicine.
[10] N. Samaan,et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. , 1983, The Journal of clinical endocrinology and metabolism.
[11] J. Eisman,et al. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women , 2005, Osteoporosis International.
[12] P. Ell,et al. Variation between femurs as measured by dual energy X-ray absorptiometry (DEXA) , 2004, European Journal of Nuclear Medicine.